https://www.selleckchem.com/pr....oducts/i-bet151-gsk1
The five-year patient survival rate was 87.1%. The only predictor of mortality was age (HR 1.07 [1.01-1.14]; p=0.024). The patients with hypocomplementemia (22%) had a lower remission rate (p=0.049), FFS ≥2 at the time of diagnosis (p=0.026), and higher levels of hematuria (p=0.004) and proteinuria (p=0.037). The FFS ≥2 at the time of diagnosis was an independent predictor of relapse (HR 8.9 [1.02-77.36]; p=0.047). Our study suggests that the baseline renal function and FFS ≥2 at the time of diagnosis are the major prognost
إعجاب
علق
شارك
